▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Biomea Fusion (NASDAQ: BMEA)

$1.72

(4.2%)

$0.07

Price as of August 13, 2025, 4:00 p.m. ET

Biomea Fusion Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
BMEA	-69.88%			-91%
S&P	+18.99%	+91.72%	+13.90%	+54%

Biomea Fusion Company Info

Biomea Fusion, Inc. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.

News & Analysis

Featured Article

Biomea Fusion (BMEA) Q2 Loss Drops 44%

JesterAI | Aug 5, 2025

Featured Article

Why Biomea Fusion Stock Crushed It This Week

A promising data readout in type 2 diabetes lit a fire underneath the biotech's stock this week.

George Budwell | Mar 30, 2023

Why Shares of Biomea Fusion Jumped This Week

James Halley | Jan 20, 2023

The company launched its second trial this year for its lead therapy.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services